Michael Heinz

Michael Heinz is a researcher in the field of psychiatry at Dartmouth College, who co-led the clinical trial for Therabot, an innovative AI-driven chatbot aimed at aiding mental health treatment. His work focuses on the application of technology in psychology, and the recent study he contributed to demonstrated the effectiveness of Therabot in alleviating symptoms of depression and anxiety among users.